Veolia WTS USA, Inc.

Trevose, PA ManufacturingNAICS 325900

Self-funded health planPlan year 2025Renews January
3,412Participants+4% vs. prior year
$8.1MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#24 of 105Manufacturing in PABy participants

Overview

Veolia WTS USA, Inc. sponsors a self-funded health plan that covered 3,412 participants in plan year 2025, up 4% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
3,412 · prior year 3,284
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Veolia WTS USA, Inc. Health and Welfare Benefit Plan for Employees, plan 501 (3,412 participants)
Stop-loss carrier
Cigna Health and Life Insurance Company and Affiliates
Broker compensation
$324K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Metropolitan Life Insurance CompanyLife, Short-term disability, Long-term disability6,048$3.8M$77K
Cigna Health and Life Insurance Company and AffiliatesStop-loss6,223$1.8M$94K
Cigna Health and Life Insurance CompanyVoluntary Critical Illness, Accidental Injury, Voluntary Hospital Care2,021$700K$153K
Eyemed Vision CareVision3,871$375K—
Cigna Health and Life Insurance Company and Affiliates (cigna)Medical608$5K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$8.1M/ year

Estimated prescription spend: 3,412 participants × $2,371 national average per member. Usually higher once dependents are counted.

$210K–$519K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$61K–$154K
Lower-cost therapeutic alternatives$90K–$188K
Generic pricing vs. actual cost$39K–$116K
PBM contract terms$20K–$61K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Veolia WTS USA, Inc.
Sponsor EIN
23-1503731
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 23-1503731 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Veolia WTS 401(k) Plan
Type
401(k) plan
Participants
4,951

About this data

Source: Veolia WTS USA, Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Veolia WTS USA, Inc..

Request a correction · Methodology